Evidence for colorectal cancer screening

The incidence of colorectal cancer (CRC) has been increasing during the past decades, and the lifetime risk for CRC in industrialised countries is about 5%. CRC is a good candidate for screening, because it is a disease with high prevalence, has recognised precursors, and early treatment is benefici...

Full description

Saved in:
Bibliographic Details
Published in:Baillière's best practice & research. Clinical gastroenterology Vol. 24; no. 4; pp. 417 - 425
Main Author: Bretthauer, Michael
Format: Journal Article
Language:English
Published: Netherlands Elsevier Ltd 01.08.2010
Elsevier Limited
Subjects:
ISSN:1521-6918, 1532-1916, 1532-1916
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract The incidence of colorectal cancer (CRC) has been increasing during the past decades, and the lifetime risk for CRC in industrialised countries is about 5%. CRC is a good candidate for screening, because it is a disease with high prevalence, has recognised precursors, and early treatment is beneficial. This paper outlines the evidence for efficacy from randomised trials for the most commonly used CRC screening tests to reduce CRC incidence and mortality in the average-risk population. Four randomised trials have investigated the effect of guaiac-based fecal occult blood screening on CRC mortality, with a combined CRC mortality risk reduction of 15–17% in an intention-to-screen analysis, and 25% for those people who attended screening. Flexible sigmoidoscopy screening has been evaluated in three randomised trials. The observed reduction in CRC incidence varied between 23 and 80%, and between 27 and 67% for CRC mortality, respectively (intention-to-screen analyses) in the trials with long follow-up time. No randomised trials exist in other CRC screening tools, included colonoscopy screening. FOBT and flexible sigmoidoscopy are the two CRC screening methods which have been tested in randomised trials and shown to reduce CRC mortality. These tests can be recommended for CRC screening.
AbstractList The incidence of colorectal cancer (CRC) has been increasing during the past decades, and the lifetime risk for CRC in industrialised countries is about 5%. CRC is a good candidate for screening, because it is a disease with high prevalence, has recognised precursors, and early treatment is beneficial. This paper outlines the evidence for efficacy from randomised trials for the most commonly used CRC screening tests to reduce CRC incidence and mortality in the average-risk population. Four randomised trials have investigated the effect of guaiac-based fecal occult blood screening on CRC mortality, with a combined CRC mortality risk reduction of 15-17% in an intention-to-screen analysis, and 25% for those people who attended screening. Flexible sigmoidoscopy screening has been evaluated in three randomised trials. The observed reduction in CRC incidence varied between 23 and 80%, and between 27 and 67% for CRC mortality, respectively (intention-to-screen analyses) in the trials with long follow-up time. No randomised trials exist in other CRC screening tools, included colonoscopy screening. FOBT and flexible sigmoidoscopy are the two CRC screening methods which have been tested in randomised trials and shown to reduce CRC mortality. These tests can be recommended for CRC screening.
The incidence of colorectal cancer (CRC) has been increasing during the past decades, and the lifetime risk for CRC in industrialised countries is about 5%. CRC is a good candidate for screening, because it is a disease with high prevalence, has recognised precursors, and early treatment is beneficial. This paper outlines the evidence for efficacy from randomised trials for the most commonly used CRC screening tests to reduce CRC incidence and mortality in the average-risk population. Four randomised trials have investigated the effect of guaiac-based fecal occult blood screening on CRC mortality, with a combined CRC mortality risk reduction of 15–17% in an intention-to-screen analysis, and 25% for those people who attended screening. Flexible sigmoidoscopy screening has been evaluated in three randomised trials. The observed reduction in CRC incidence varied between 23 and 80%, and between 27 and 67% for CRC mortality, respectively (intention-to-screen analyses) in the trials with long follow-up time. No randomised trials exist in other CRC screening tools, included colonoscopy screening. FOBT and flexible sigmoidoscopy are the two CRC screening methods which have been tested in randomised trials and shown to reduce CRC mortality. These tests can be recommended for CRC screening.
The incidence of colorectal cancer (CRC) has been increasing during the past decades, and the lifetime risk for CRC in industrialised countries is about 5%. CRC is a good candidate for screening, because it is a disease with high prevalence, has recognised precursors, and early treatment is beneficial. This paper outlines the evidence for efficacy from randomised trials for the most commonly used CRC screening tests to reduce CRC incidence and mortality in the average-risk population. Four randomised trials have investigated the effect of guaiac-based fecal occult blood screening on CRC mortality, with a combined CRC mortality risk reduction of 15-17% in an intention-to-screen analysis, and 25% for those people who attended screening. Flexible sigmoidoscopy screening has been evaluated in three randomised trials. The observed reduction in CRC incidence varied between 23 and 80%, and between 27 and 67% for CRC mortality, respectively (intention-to-screen analyses) in the trials with long follow-up time. No randomised trials exist in other CRC screening tools, included colonoscopy screening. FOBT and flexible sigmoidoscopy are the two CRC screening methods which have been tested in randomised trials and shown to reduce CRC mortality. These tests can be recommended for CRC screening.The incidence of colorectal cancer (CRC) has been increasing during the past decades, and the lifetime risk for CRC in industrialised countries is about 5%. CRC is a good candidate for screening, because it is a disease with high prevalence, has recognised precursors, and early treatment is beneficial. This paper outlines the evidence for efficacy from randomised trials for the most commonly used CRC screening tests to reduce CRC incidence and mortality in the average-risk population. Four randomised trials have investigated the effect of guaiac-based fecal occult blood screening on CRC mortality, with a combined CRC mortality risk reduction of 15-17% in an intention-to-screen analysis, and 25% for those people who attended screening. Flexible sigmoidoscopy screening has been evaluated in three randomised trials. The observed reduction in CRC incidence varied between 23 and 80%, and between 27 and 67% for CRC mortality, respectively (intention-to-screen analyses) in the trials with long follow-up time. No randomised trials exist in other CRC screening tools, included colonoscopy screening. FOBT and flexible sigmoidoscopy are the two CRC screening methods which have been tested in randomised trials and shown to reduce CRC mortality. These tests can be recommended for CRC screening.
Author Bretthauer, Michael
Author_xml – sequence: 1
  givenname: Michael
  surname: Bretthauer
  fullname: Bretthauer, Michael
  email: michael.bretthauer@rikshospitalet.no
  organization: Centre for Colorectal Cancer Screening, The Cancer Registry of Norway, Oslo University Hospital, P.O. Box 5313 Majorstuen, N-0304 Oslo, Norway
BackLink https://www.ncbi.nlm.nih.gov/pubmed/20833346$$D View this record in MEDLINE/PubMed
BookMark eNqFkl1rFDEUhoNU7If-AG9kwYt6M-vJ9wyCIKVaoeCFen3IZs6UrLPJmswW-u-bYVuEBdurfL3Pe5L35JQdxRSJsbcclhy4-bherrY3SwF1DWYJoF-wE66laHjHzdE8F7wxHW-P2Wkpa4AKdd0rdiyglVIqc8I-XN6GnqKnxZDywqcxZfKTGxfe1c28KD4TxRBvXrOXgxsLvXkYz9jvr5e_Lq6a6x_fvl98uW68avXU8N6uhLFqMMJDC1z7fnBaQGetaVeDtdQrLcFCq7gXQPXIabKtrRAMIOUZO9_7bnP6u6My4SYUT-PoIqVdQasVgJJKVeX7A-U67XKsl0MOUljNa9mqeveg2q021OM2h43Ld_gYQRXYvcDnVEqmAX2Y3BRSnLILY_XCOWxcYw0b57ARDNawK8kPyEfzp5hPe4ZqhreBMhYf5vz7MAePfQpP0p8PaD-GGLwb_9AdlX_vxyIQ8Of8Aeb-89p6MIZXg-7_Bs8UvwcGybpW
CODEN BPRCB6
CitedBy_id crossref_primary_10_1016_j_ejca_2014_12_007
crossref_primary_10_2217_crc_15_4
crossref_primary_10_1007_s11888_013_0201_6
crossref_primary_10_1007_s11888_013_0203_4
crossref_primary_10_1016_j_canlet_2011_12_030
crossref_primary_10_3892_ol_2016_5027
crossref_primary_10_1186_1472_6947_11_74
crossref_primary_10_1016_j_canlet_2012_12_015
crossref_primary_10_1111_apm_12397
crossref_primary_10_1111_codi_14033
crossref_primary_10_1007_s13187_025_02608_z
crossref_primary_10_1097_NCC_0000000000000367
crossref_primary_10_1186_1479_5876_11_253
crossref_primary_10_1111_j_1365_2796_2011_02399_x
crossref_primary_10_1186_1748_5908_7_51
crossref_primary_10_1371_journal_pone_0092921
crossref_primary_10_1186_1476_4598_13_21
crossref_primary_10_1371_journal_pone_0065821
crossref_primary_10_1007_s13277_014_1845_9
crossref_primary_10_1016_j_synres_2020_100068
crossref_primary_10_1016_j_ejca_2013_03_006
crossref_primary_10_1002_adtp_201900127
crossref_primary_10_1002_jcla_24878
crossref_primary_10_1002_agt2_740
crossref_primary_10_1007_s00108_014_3601_z
crossref_primary_10_1007_s00432_015_1972_8
crossref_primary_10_1097_MCG_0b013e318233a986
crossref_primary_10_1155_2011_792362
crossref_primary_10_3109_1354750X_2015_1068860
crossref_primary_10_5812_ijcm_7743
crossref_primary_10_3892_ol_2013_1376
crossref_primary_10_5604_01_3001_0053_3997
crossref_primary_10_1515_amma_2016_0046
crossref_primary_10_1158_1940_6207_CAPR_13_0053
crossref_primary_10_1111_apm_12161
crossref_primary_10_1186_1476_4598_10_85
crossref_primary_10_1371_journal_pone_0040476
crossref_primary_10_3390_ijms20236082
crossref_primary_10_1007_s00726_016_2215_2
crossref_primary_10_5301_JBM_2012_9107
crossref_primary_10_1111_j_1365_2516_2012_02846_x
crossref_primary_10_14442_general_14_40
crossref_primary_10_1007_s11306_011_0357_5
crossref_primary_10_1155_2016_6830713
crossref_primary_10_1007_s00535_016_1261_6
Cites_doi 10.3109/00365528509091663
10.7326/0003-4819-149-9-200811040-00243
10.1016/S0140-6736(96)03430-7
10.1053/j.gastro.2005.10.032
10.7326/0003-4819-149-9-200811040-00245
10.1016/S0140-6736(02)08268-5
10.1258/096914107782912059
10.1136/bmj.c2831
10.1056/NEJMp0805920
10.1136/bmj.b1846
10.1056/NEJMe0903924
10.1097/01.ede.0000181313.61948.76
10.1136/gut.50.1.29
10.1053/j.gastro.2008.02.002
10.1136/gut.2009.192948
10.1053/j.gastro.2010.03.001
10.1016/S0140-6736(96)03386-7
10.1002/bjs.6136
10.1056/NEJM200007203430302
10.1053/j.gastro.2008.03.040
10.1080/003655299750026443
10.1053/j.gastro.2004.01.023
10.1080/00365520310003002
10.7326/0003-4819-150-3-200902030-00005
10.1056/NEJM199305133281901
10.1016/S0140-6736(10)60551-X
10.1093/jnci/dji175
10.1136/gut.2004.052282
10.1136/bmj.a2261
10.1080/00365520410003182
10.1055/s-0029-1244131
10.1111/j.1572-0241.2008.01875.x
10.1093/jnci/91.5.434
10.1056/NEJM200011303432203
10.1093/jnci/94.23.1763
10.1007/s10350-004-6496-2
10.1136/gut.45.4.588
ContentType Journal Article
Copyright 2010 Elsevier Ltd
Elsevier Ltd
Copyright © 2010 Elsevier Ltd. All rights reserved.
Copyright_xml – notice: 2010 Elsevier Ltd
– notice: Elsevier Ltd
– notice: Copyright © 2010 Elsevier Ltd. All rights reserved.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
K9.
NAPCQ
7X8
DOI 10.1016/j.bpg.2010.06.005
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
DatabaseTitleList MEDLINE


ProQuest Health & Medical Complete (Alumni)

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1532-1916
EndPage 425
ExternalDocumentID 2731703541
20833346
10_1016_j_bpg_2010_06_005
S1521691810000661
1_s2_0_S1521691810000661
Genre Journal Article
Review
GroupedDBID ---
--K
--M
.1-
.FO
.~1
0R~
1B1
1P~
1RT
1~.
1~5
4.4
457
4G.
53G
5GY
5VS
7-5
71M
8P~
AABNK
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AATTM
AAXKI
AAXUO
AAYWO
ABBQC
ABMAC
ABMZM
ABWVN
ABXDB
ACDAQ
ACGFS
ACIEU
ACLOT
ACRLP
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADMUD
ADNMO
AEBSH
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AFJKZ
AFPUW
AFRHN
AFTJW
AFXIZ
AGHFR
AGQPQ
AGUBO
AGYEJ
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
ASPBG
AVWKF
AXJTR
AZFZN
BKEYQ
BKOJK
BLXMC
BNPGV
BPHCQ
BVXVI
CAG
COF
DU5
EBS
EFJIC
EFKBS
EFLBG
EJD
EMOBN
EO8
EO9
EP2
EP3
EX3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-Q
GBLVA
HVGLF
HZ~
IHE
J1W
KOM
M41
MO0
N9A
O-L
O9-
OAUVE
OC.
ON0
OZT
P-8
P-9
P2P
PC.
Q38
R2-
ROL
RPZ
SDF
SDG
SEL
SES
SEW
SSH
SSZ
SV3
T5K
UHS
WOW
Z5R
~G-
~HD
7RV
AACTN
AFCTW
AFKWA
AJOXV
AMFUW
AZQEC
BENPR
M0T
M1P
M2O
RIG
AAIAV
ABLVK
ABYKQ
AJBFU
LCYCR
9DU
AAYXX
CITATION
AGCQF
AGRNS
CGR
CUY
CVF
ECM
EIF
NPM
K9.
NAPCQ
7X8
ID FETCH-LOGICAL-c485t-1d7b2674f62c08015cdfa52097768bf77ed453070841c20e520a5e7872670f033
ISICitedReferencesCount 58
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000283392300007&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1521-6918
1532-1916
IngestDate Wed Oct 01 15:04:08 EDT 2025
Sat Oct 25 11:06:26 EDT 2025
Mon Jul 21 06:05:47 EDT 2025
Tue Nov 18 22:34:07 EST 2025
Sat Nov 29 03:20:25 EST 2025
Fri Feb 23 02:29:29 EST 2024
Sun Feb 23 10:19:56 EST 2025
Tue Oct 14 19:25:38 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords Colorectal cancer screening
Language English
License https://www.elsevier.com/tdm/userlicense/1.0
Copyright © 2010 Elsevier Ltd. All rights reserved.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c485t-1d7b2674f62c08015cdfa52097768bf77ed453070841c20e520a5e7872670f033
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
content type line 14
ObjectType-Undefined-1
ObjectType-Feature-3
ObjectType-Article-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
PMID 20833346
PQID 1032751209
PQPubID 1226366
PageCount 9
ParticipantIDs proquest_miscellaneous_754004344
proquest_journals_1032751209
pubmed_primary_20833346
crossref_citationtrail_10_1016_j_bpg_2010_06_005
crossref_primary_10_1016_j_bpg_2010_06_005
elsevier_sciencedirect_doi_10_1016_j_bpg_2010_06_005
elsevier_clinicalkeyesjournals_1_s2_0_S1521691810000661
elsevier_clinicalkey_doi_10_1016_j_bpg_2010_06_005
PublicationCentury 2000
PublicationDate 2010-08-01
PublicationDateYYYYMMDD 2010-08-01
PublicationDate_xml – month: 08
  year: 2010
  text: 2010-08-01
  day: 01
PublicationDecade 2010
PublicationPlace Netherlands
PublicationPlace_xml – name: Netherlands
– name: Kidlington
PublicationTitle Baillière's best practice & research. Clinical gastroenterology
PublicationTitleAlternate Best Pract Res Clin Gastroenterol
PublicationYear 2010
Publisher Elsevier Ltd
Elsevier Limited
Publisher_xml – name: Elsevier Ltd
– name: Elsevier Limited
References Imperiale, Wagner, Lin, Larkin, Rogge, Ransohoff (bib27) 2000; 343
Mandel, Bond, Church, Snover, Bradley, Schuman (bib16) 1993; 328
Zheng, Chen, Liu, Ma, Yu, Chen (bib22) 2003; 46
van Rossum, van Rijn, Laheij, van Oijen, Fockens, van Krieken (bib10) 2008; 135
Levin, Farraye, Schoen, Hoff, Atkin, Bond (bib26) 2005; 54
Bretthauer, Skovlund, Grotmol, Thiis-Evensen, Gondal, Huppertz-Hauss (bib29) 2003; 2003
Lindholm, Brevinge, Haglin (bib20) 2008; 95
Whitlock, Lin, Liles, Beil, Fu (bib8) 2008; 149
Levin, Lieberman, McFarland, Andrews, Brooks, Dash (bib25) 2008; 134
Hundt, Haug, Brenner (bib11) 2009; 150
Fracchia, Senore, Armaroli, Ferraris, Placido, Musso (bib30) 2010; 42
Hoff, Grotmol, Skovlund, Bretthauer (bib33) 2009; 338
Altekruse SF, Kosary CL, Krapcho M, Neyman N, Aminou R, Waldron W, et al. editors. SEER Cancer Statistics Review, 1975–2007, National Cancer Institute. Bethesda, MD.
Hardcastle, Chamberlain, Robinson, Moss, Amar (bib18) 1996; 348
Bretthauer (bib35) 2010; 340
Hewitson, Glasziou, Watson, Towler, Irvig (bib7) 2008; 103
UK flexible sigmoidoscopy screening trial investigators (bib39) 2002; 359
Hanley (bib23) 2005; 16
Jorgensen, Kronborg, Fenger (bib14) 2002; 50
Mandel, Church, Bond, Ederer, Geisser, Mongin (bib21) 2000; 30
von Karsa, Anttila, Ronco, Ponti, Malila, Arbyn (bib6) 2008
Cuzick, Cafferty, Edwards, Møller, Duffy (bib34) 2007; 14
Segnan, Senore, Andreoni, Aste, Bonelli, Crosta (bib37) 2002; 94
Atkin, Rogers, Cardwell, Cook, Cuzick, Wardle (bib28) 2004; 126
Ransohoff (bib42) 2005; 129
Malila, Oivanen, Malminiemi, Hakama (bib9) 2008; 337
Kronborg, Jorgensen, Fenger, Rasmussen (bib15) 2004; 39
bib43
Redberg, Walsh (bib4) 2008; 359
Mandel, Church, Ederer, Bond (bib17) 1999; 91
Robinson, Hardcastle, Moss, Amar, Chamberlain, Armitage (bib19) 1999; 45
Wilson, Jungner (bib3) 1968
Allison (bib12) 2010; 138
Weissfeld, Schoen, Pinsky, Bresalier, Church, Yurgalevitch (bib36) 2005; 97
Thiis-Evensen, Hoff, Sauar, Langmark, Majak, Vatn (bib31) 1999; 34
Northern-European Initiative on colorectal cancer (NordICC) (bib44)
Kronborg, Fenger, Olsen, Jørgensen, Søndergaard (bib13) 1996; 348
Hoff, Dominitz (bib41) 2010; 59
Atkin, Edwards, Kralj-Hans, Wooldrage, Hart, Northover (bib32) 2010; 375
Gondal, Grotmol, Hofstad, Bretthauer, Eide, Hoff (bib40) 2003; 38
Bretthauer (bib5) 2009; 361
U.S. Preventive Services Task Force Screening for Colorectal Cancer (bib24) 2008; 149
Globocan (bib1) 2002
Hoff, Vatn, Gjone, Larsen, Sauar (bib38) 1985; 20
Fracchia (10.1016/j.bpg.2010.06.005_bib30) 2010; 42
Cuzick (10.1016/j.bpg.2010.06.005_bib34) 2007; 14
Mandel (10.1016/j.bpg.2010.06.005_bib21) 2000; 30
von Karsa (10.1016/j.bpg.2010.06.005_bib6) 2008
Zheng (10.1016/j.bpg.2010.06.005_bib22) 2003; 46
Hanley (10.1016/j.bpg.2010.06.005_bib23) 2005; 16
Whitlock (10.1016/j.bpg.2010.06.005_bib8) 2008; 149
Kronborg (10.1016/j.bpg.2010.06.005_bib15) 2004; 39
Atkin (10.1016/j.bpg.2010.06.005_bib32) 2010; 375
Mandel (10.1016/j.bpg.2010.06.005_bib17) 1999; 91
Weissfeld (10.1016/j.bpg.2010.06.005_bib36) 2005; 97
Levin (10.1016/j.bpg.2010.06.005_bib25) 2008; 134
Kronborg (10.1016/j.bpg.2010.06.005_bib13) 1996; 348
Hoff (10.1016/j.bpg.2010.06.005_bib41) 2010; 59
Imperiale (10.1016/j.bpg.2010.06.005_bib27) 2000; 343
10.1016/j.bpg.2010.06.005_bib2
Lindholm (10.1016/j.bpg.2010.06.005_bib20) 2008; 95
Hoff (10.1016/j.bpg.2010.06.005_bib38) 1985; 20
Bretthauer (10.1016/j.bpg.2010.06.005_bib29) 2003; 2003
Ransohoff (10.1016/j.bpg.2010.06.005_bib42) 2005; 129
Hardcastle (10.1016/j.bpg.2010.06.005_bib18) 1996; 348
Wilson (10.1016/j.bpg.2010.06.005_bib3) 1968
Redberg (10.1016/j.bpg.2010.06.005_bib4) 2008; 359
Robinson (10.1016/j.bpg.2010.06.005_bib19) 1999; 45
Allison (10.1016/j.bpg.2010.06.005_bib12) 2010; 138
Bretthauer (10.1016/j.bpg.2010.06.005_bib35) 2010; 340
Levin (10.1016/j.bpg.2010.06.005_bib26) 2005; 54
Segnan (10.1016/j.bpg.2010.06.005_bib37) 2002; 94
Bretthauer (10.1016/j.bpg.2010.06.005_bib5) 2009; 361
Jorgensen (10.1016/j.bpg.2010.06.005_bib14) 2002; 50
Atkin (10.1016/j.bpg.2010.06.005_bib28) 2004; 126
Northern-European Initiative on colorectal cancer (NordICC) (10.1016/j.bpg.2010.06.005_bib44)
Mandel (10.1016/j.bpg.2010.06.005_bib16) 1993; 328
Hundt (10.1016/j.bpg.2010.06.005_bib11) 2009; 150
Malila (10.1016/j.bpg.2010.06.005_bib9) 2008; 337
Thiis-Evensen (10.1016/j.bpg.2010.06.005_bib31) 1999; 34
U.S. Preventive Services Task Force Screening for Colorectal Cancer (10.1016/j.bpg.2010.06.005_bib24) 2008; 149
Gondal (10.1016/j.bpg.2010.06.005_bib40) 2003; 38
UK flexible sigmoidoscopy screening trial investigators (10.1016/j.bpg.2010.06.005_bib39) 2002; 359
van Rossum (10.1016/j.bpg.2010.06.005_bib10) 2008; 135
Globocan (10.1016/j.bpg.2010.06.005_bib1)
Hoff (10.1016/j.bpg.2010.06.005_bib33) 2009; 338
Hewitson (10.1016/j.bpg.2010.06.005_bib7) 2008; 103
References_xml – volume: 359
  start-page: 2309
  year: 2008
  end-page: 2311
  ident: bib4
  article-title: Pay now, benefits may follow — the case of cardiac computed tomographic angiography
  publication-title: N Engl J Med
– volume: 359
  start-page: 1291
  year: 2002
  end-page: 1300
  ident: bib39
  article-title: Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK multicentre randomised trial
  publication-title: Lancet
– volume: 348
  start-page: 1467
  year: 1996
  end-page: 1471
  ident: bib13
  article-title: Randomised study of screening for colorectal cancer with faecal-occult-blood test
  publication-title: Lancet
– volume: 337
  start-page: a2261
  year: 2008
  ident: bib9
  article-title: Test, episode, and programme sensitivities of screening for colorectal cancer as a public health policy in Finland: experimental design
  publication-title: Br Med J
– volume: 149
  start-page: 638
  year: 2008
  end-page: 658
  ident: bib8
  article-title: Screening for colorectal cancer: a targeted, updated systematic review for the U.S. Preventive Services Task Force
  publication-title: Ann Intern Med
– ident: bib43
  article-title: Colorectal cancer screening in average-risk population: immunochemical 11 fecal occult blood testing versus colonoscopy
– volume: 54
  start-page: 807
  year: 2005
  end-page: 813
  ident: bib26
  article-title: Quality in the technical performance of screening flexible sigmoidoscopy: recommendations of an international multi-society task group
  publication-title: Gut
– volume: 34
  start-page: 414
  year: 1999
  end-page: 420
  ident: bib31
  article-title: Population-based surveillance by colonoscopy: effect on the incidence of colorectal cancer. Telemark Polyp Study I
  publication-title: Scand J Gastroenterol
– volume: 361
  start-page: 300
  year: 2009
  end-page: 301
  ident: bib5
  article-title: The capsule and colorectal cancer screening – the crux of the matter
  publication-title: N Engl J Med
– volume: 134
  start-page: 1570
  year: 2008
  end-page: 1595
  ident: bib25
  article-title: Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American cancer society, the US multi-society task force on colorectal cancer, and the American College of Radiology
  publication-title: Gastroenterology
– volume: 343
  start-page: 169
  year: 2000
  end-page: 174
  ident: bib27
  article-title: Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings
  publication-title: N Engl J Med
– volume: 2003
  start-page: 635
  year: 2003
  end-page: 642
  ident: bib29
  article-title: Inter-endoscopist variation in polyp and neoplasia pick-up rates in flexible sigmoidoscopy for colorectal cancer screening
  publication-title: Scand J Gastroenterol
– year: 1968
  ident: bib3
  article-title: Principles and practice of mass screening for disease
– volume: 16
  start-page: 786
  year: 2005
  end-page: 790
  ident: bib23
  article-title: Analysis of mortality data from cancer screening studies. Looking in the right window
  publication-title: Epidemiology
– volume: 149
  start-page: 627
  year: 2008
  end-page: 637
  ident: bib24
  article-title: U.S. preventive services task force recommendation statement
  publication-title: Ann Intern Med
– volume: 38
  start-page: 635
  year: 2003
  end-page: 642
  ident: bib40
  article-title: The Norwegian Colorectal Cancer Prevention (NORCCAP) screening study: baseline findings and implementations for clinical work-up in age groups 50–64 years
  publication-title: Scand J Gastroenterol
– volume: 14
  start-page: 178
  year: 2007
  end-page: 185
  ident: bib34
  article-title: Surrogate endpoints for cancer screening trials: general principles and an illustration using the UK flexible sigmoidoscopy screening trial
  publication-title: J Med Screen
– volume: 103
  start-page: 1541
  year: 2008
  end-page: 1549
  ident: bib7
  article-title: Cochran systematic review of colorectal cancer screening using the fecal occult blood test (Hemoccult): an update
  publication-title: Am J Gastroenterol
– volume: 375
  start-page: 1624
  year: 2010
  end-page: 1633
  ident: bib32
  article-title: Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial
  publication-title: Lancet
– volume: 39
  start-page: 846
  year: 2004
  end-page: 851
  ident: bib15
  article-title: Randomized study of biennial screening with a faecal occult blood test: results after nine screening rounds
  publication-title: Scand J Gastroenterol
– volume: 91
  start-page: 434
  year: 1999
  end-page: 437
  ident: bib17
  article-title: Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood
  publication-title: J Natl Cancer Inst
– volume: 42
  start-page: 448
  year: 2010
  end-page: 455
  ident: bib30
  article-title: Assessment of the multiple components of the variability in the adenoma detection rate in sigmoidoscopy screening, and lessons for training
  publication-title: Endosocpy
– volume: 340
  start-page: c2831
  year: 2010
  ident: bib35
  article-title: Which tool is best for colorectal cancer screening? Flexible sigmoidoscopy shows promise, but randomised data are needed
  publication-title: Br Med J
– volume: 97
  start-page: 989
  year: 2005
  end-page: 997
  ident: bib36
  article-title: Flexible sigmoidoscopy in the PLCO cancer screening trial: results from the baseline screening examination of a randomized trial
  publication-title: J Natl Cancer Inst
– volume: 126
  start-page: 1247
  year: 2004
  end-page: 1256
  ident: bib28
  article-title: Wide variation in adenoma detection rates at screening flexible sigmoidoscopy
  publication-title: Gastroenterology
– volume: 50
  start-page: 29
  year: 2002
  end-page: 32
  ident: bib14
  article-title: A randomised study of screening for colorectal cancer using faecal occult blood testing: results after 13 years and seven biennial screening rounds
  publication-title: Gut
– volume: 348
  start-page: 1472
  year: 1996
  end-page: 1477
  ident: bib18
  article-title: Randomised controlled trial of faecal-occult-blood screening for colorectal cancer
  publication-title: Lancet
– volume: 46
  start-page: 51
  year: 2003
  end-page: 58
  ident: bib22
  article-title: Cluster randomization trial of sequence mass screening for colorectal cancer
  publication-title: Dis Colon Rectum
– year: 2008
  ident: bib6
  article-title: Cancer screening in the European Union. Report on the implementation of the Council recommendation on cancer screening – First Report
– volume: 338
  start-page: b1846
  year: 2009
  ident: bib33
  article-title: Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised trial
  publication-title: Br Med J
– volume: 95
  start-page: 1029
  year: 2008
  end-page: 1036
  ident: bib20
  article-title: Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer
  publication-title: Br J Surg
– volume: 94
  start-page: 1763
  year: 2002
  end-page: 1772
  ident: bib37
  article-title: Baseline findings of the Italian multicenter randomized controlled trial of “once-only sigmoidoccopy”—SCORE
  publication-title: J Natl Cancer Inst
– reference: Altekruse SF, Kosary CL, Krapcho M, Neyman N, Aminou R, Waldron W, et al. editors. SEER Cancer Statistics Review, 1975–2007, National Cancer Institute. Bethesda, MD.
– ident: bib44
– volume: 20
  start-page: 351
  year: 1985
  end-page: 355
  ident: bib38
  article-title: Epidemiology of polyps in the rectum and sigmoid colon. design of a population screening study
  publication-title: Scand J Gastroenterol
– year: 2002
  ident: bib1
  article-title: database
– volume: 138
  start-page: 1648
  year: 2010
  end-page: 1652
  ident: bib12
  article-title: Colorectal cancer screening guidelines: the importance of evidence and transparency
  publication-title: Gastroenterology
– volume: 45
  start-page: 588
  year: 1999
  end-page: 592
  ident: bib19
  article-title: The risks of screening: data from the Nottingham randomised controlled trial of faecal occult blood screening for colorectal cancer
  publication-title: Gut
– volume: 59
  start-page: 407
  year: 2010
  end-page: 414
  ident: bib41
  article-title: Contrasting US and European approaches to colorectal cancer screening: which is best?
  publication-title: Gut
– volume: 150
  start-page: 162
  year: 2009
  end-page: 169
  ident: bib11
  article-title: Comparative evaluation of immunochemical fecal occult blood tests for colorectal adenoma detection
  publication-title: Ann Intern Med
– volume: 129
  start-page: 1815
  year: 2005
  ident: bib42
  article-title: Have we oversold colonoscopy?
  publication-title: Gastroenterology
– volume: 328
  start-page: 1365
  year: 1993
  end-page: 1371
  ident: bib16
  article-title: Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study
  publication-title: N Engl J Med
– volume: 30
  start-page: 1603
  year: 2000
  end-page: 1607
  ident: bib21
  article-title: The effect of fecal occult-blood screening on the incidence of colorectal cancer
  publication-title: N Engl J Med
– volume: 135
  start-page: 82
  year: 2008
  end-page: 90
  ident: bib10
  article-title: Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population
  publication-title: Gastroenterology
– volume: 20
  start-page: 351
  year: 1985
  ident: 10.1016/j.bpg.2010.06.005_bib38
  article-title: Epidemiology of polyps in the rectum and sigmoid colon. design of a population screening study
  publication-title: Scand J Gastroenterol
  doi: 10.3109/00365528509091663
– volume: 149
  start-page: 627
  year: 2008
  ident: 10.1016/j.bpg.2010.06.005_bib24
  article-title: U.S. preventive services task force recommendation statement
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-149-9-200811040-00243
– volume: 348
  start-page: 1467
  year: 1996
  ident: 10.1016/j.bpg.2010.06.005_bib13
  article-title: Randomised study of screening for colorectal cancer with faecal-occult-blood test
  publication-title: Lancet
  doi: 10.1016/S0140-6736(96)03430-7
– year: 1968
  ident: 10.1016/j.bpg.2010.06.005_bib3
– volume: 129
  start-page: 1815
  year: 2005
  ident: 10.1016/j.bpg.2010.06.005_bib42
  article-title: Have we oversold colonoscopy?
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2005.10.032
– volume: 149
  start-page: 638
  year: 2008
  ident: 10.1016/j.bpg.2010.06.005_bib8
  article-title: Screening for colorectal cancer: a targeted, updated systematic review for the U.S. Preventive Services Task Force
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-149-9-200811040-00245
– volume: 359
  start-page: 1291
  year: 2002
  ident: 10.1016/j.bpg.2010.06.005_bib39
  article-title: Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK multicentre randomised trial
  publication-title: Lancet
  doi: 10.1016/S0140-6736(02)08268-5
– volume: 14
  start-page: 178
  year: 2007
  ident: 10.1016/j.bpg.2010.06.005_bib34
  article-title: Surrogate endpoints for cancer screening trials: general principles and an illustration using the UK flexible sigmoidoscopy screening trial
  publication-title: J Med Screen
  doi: 10.1258/096914107782912059
– volume: 340
  start-page: c2831
  year: 2010
  ident: 10.1016/j.bpg.2010.06.005_bib35
  article-title: Which tool is best for colorectal cancer screening? Flexible sigmoidoscopy shows promise, but randomised data are needed
  publication-title: Br Med J
  doi: 10.1136/bmj.c2831
– volume: 359
  start-page: 2309
  year: 2008
  ident: 10.1016/j.bpg.2010.06.005_bib4
  article-title: Pay now, benefits may follow — the case of cardiac computed tomographic angiography
  publication-title: N Engl J Med
  doi: 10.1056/NEJMp0805920
– volume: 338
  start-page: b1846
  year: 2009
  ident: 10.1016/j.bpg.2010.06.005_bib33
  article-title: Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised trial
  publication-title: Br Med J
  doi: 10.1136/bmj.b1846
– volume: 361
  start-page: 300
  year: 2009
  ident: 10.1016/j.bpg.2010.06.005_bib5
  article-title: The capsule and colorectal cancer screening – the crux of the matter
  publication-title: N Engl J Med
  doi: 10.1056/NEJMe0903924
– year: 2008
  ident: 10.1016/j.bpg.2010.06.005_bib6
– ident: 10.1016/j.bpg.2010.06.005_bib2
– volume: 16
  start-page: 786
  year: 2005
  ident: 10.1016/j.bpg.2010.06.005_bib23
  article-title: Analysis of mortality data from cancer screening studies. Looking in the right window
  publication-title: Epidemiology
  doi: 10.1097/01.ede.0000181313.61948.76
– volume: 50
  start-page: 29
  year: 2002
  ident: 10.1016/j.bpg.2010.06.005_bib14
  article-title: A randomised study of screening for colorectal cancer using faecal occult blood testing: results after 13 years and seven biennial screening rounds
  publication-title: Gut
  doi: 10.1136/gut.50.1.29
– volume: 2003
  start-page: 635
  issue: 38
  year: 2003
  ident: 10.1016/j.bpg.2010.06.005_bib29
  article-title: Inter-endoscopist variation in polyp and neoplasia pick-up rates in flexible sigmoidoscopy for colorectal cancer screening
  publication-title: Scand J Gastroenterol
– volume: 134
  start-page: 1570
  year: 2008
  ident: 10.1016/j.bpg.2010.06.005_bib25
  article-title: Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American cancer society, the US multi-society task force on colorectal cancer, and the American College of Radiology
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2008.02.002
– volume: 59
  start-page: 407
  year: 2010
  ident: 10.1016/j.bpg.2010.06.005_bib41
  article-title: Contrasting US and European approaches to colorectal cancer screening: which is best?
  publication-title: Gut
  doi: 10.1136/gut.2009.192948
– volume: 138
  start-page: 1648
  year: 2010
  ident: 10.1016/j.bpg.2010.06.005_bib12
  article-title: Colorectal cancer screening guidelines: the importance of evidence and transparency
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2010.03.001
– volume: 348
  start-page: 1472
  year: 1996
  ident: 10.1016/j.bpg.2010.06.005_bib18
  article-title: Randomised controlled trial of faecal-occult-blood screening for colorectal cancer
  publication-title: Lancet
  doi: 10.1016/S0140-6736(96)03386-7
– volume: 95
  start-page: 1029
  year: 2008
  ident: 10.1016/j.bpg.2010.06.005_bib20
  article-title: Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer
  publication-title: Br J Surg
  doi: 10.1002/bjs.6136
– volume: 343
  start-page: 169
  year: 2000
  ident: 10.1016/j.bpg.2010.06.005_bib27
  article-title: Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings
  publication-title: N Engl J Med
  doi: 10.1056/NEJM200007203430302
– volume: 135
  start-page: 82
  year: 2008
  ident: 10.1016/j.bpg.2010.06.005_bib10
  article-title: Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2008.03.040
– volume: 34
  start-page: 414
  year: 1999
  ident: 10.1016/j.bpg.2010.06.005_bib31
  article-title: Population-based surveillance by colonoscopy: effect on the incidence of colorectal cancer. Telemark Polyp Study I
  publication-title: Scand J Gastroenterol
  doi: 10.1080/003655299750026443
– volume: 126
  start-page: 1247
  year: 2004
  ident: 10.1016/j.bpg.2010.06.005_bib28
  article-title: Wide variation in adenoma detection rates at screening flexible sigmoidoscopy
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2004.01.023
– volume: 38
  start-page: 635
  year: 2003
  ident: 10.1016/j.bpg.2010.06.005_bib40
  article-title: The Norwegian Colorectal Cancer Prevention (NORCCAP) screening study: baseline findings and implementations for clinical work-up in age groups 50–64 years
  publication-title: Scand J Gastroenterol
  doi: 10.1080/00365520310003002
– ident: 10.1016/j.bpg.2010.06.005_bib1
– volume: 150
  start-page: 162
  year: 2009
  ident: 10.1016/j.bpg.2010.06.005_bib11
  article-title: Comparative evaluation of immunochemical fecal occult blood tests for colorectal adenoma detection
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-150-3-200902030-00005
– volume: 328
  start-page: 1365
  year: 1993
  ident: 10.1016/j.bpg.2010.06.005_bib16
  article-title: Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study
  publication-title: N Engl J Med
  doi: 10.1056/NEJM199305133281901
– volume: 375
  start-page: 1624
  year: 2010
  ident: 10.1016/j.bpg.2010.06.005_bib32
  article-title: Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial
  publication-title: Lancet
  doi: 10.1016/S0140-6736(10)60551-X
– volume: 97
  start-page: 989
  year: 2005
  ident: 10.1016/j.bpg.2010.06.005_bib36
  article-title: Flexible sigmoidoscopy in the PLCO cancer screening trial: results from the baseline screening examination of a randomized trial
  publication-title: J Natl Cancer Inst
  doi: 10.1093/jnci/dji175
– volume: 54
  start-page: 807
  year: 2005
  ident: 10.1016/j.bpg.2010.06.005_bib26
  article-title: Quality in the technical performance of screening flexible sigmoidoscopy: recommendations of an international multi-society task group
  publication-title: Gut
  doi: 10.1136/gut.2004.052282
– volume: 337
  start-page: a2261
  year: 2008
  ident: 10.1016/j.bpg.2010.06.005_bib9
  article-title: Test, episode, and programme sensitivities of screening for colorectal cancer as a public health policy in Finland: experimental design
  publication-title: Br Med J
  doi: 10.1136/bmj.a2261
– volume: 39
  start-page: 846
  year: 2004
  ident: 10.1016/j.bpg.2010.06.005_bib15
  article-title: Randomized study of biennial screening with a faecal occult blood test: results after nine screening rounds
  publication-title: Scand J Gastroenterol
  doi: 10.1080/00365520410003182
– volume: 42
  start-page: 448
  year: 2010
  ident: 10.1016/j.bpg.2010.06.005_bib30
  article-title: Assessment of the multiple components of the variability in the adenoma detection rate in sigmoidoscopy screening, and lessons for training
  publication-title: Endosocpy
  doi: 10.1055/s-0029-1244131
– volume: 103
  start-page: 1541
  year: 2008
  ident: 10.1016/j.bpg.2010.06.005_bib7
  article-title: Cochran systematic review of colorectal cancer screening using the fecal occult blood test (Hemoccult): an update
  publication-title: Am J Gastroenterol
  doi: 10.1111/j.1572-0241.2008.01875.x
– volume: 91
  start-page: 434
  year: 1999
  ident: 10.1016/j.bpg.2010.06.005_bib17
  article-title: Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood
  publication-title: J Natl Cancer Inst
  doi: 10.1093/jnci/91.5.434
– volume: 30
  start-page: 1603
  issue: 343
  year: 2000
  ident: 10.1016/j.bpg.2010.06.005_bib21
  article-title: The effect of fecal occult-blood screening on the incidence of colorectal cancer
  publication-title: N Engl J Med
  doi: 10.1056/NEJM200011303432203
– volume: 94
  start-page: 1763
  year: 2002
  ident: 10.1016/j.bpg.2010.06.005_bib37
  article-title: Baseline findings of the Italian multicenter randomized controlled trial of “once-only sigmoidoccopy”—SCORE
  publication-title: J Natl Cancer Inst
  doi: 10.1093/jnci/94.23.1763
– ident: 10.1016/j.bpg.2010.06.005_bib44
– volume: 46
  start-page: 51
  year: 2003
  ident: 10.1016/j.bpg.2010.06.005_bib22
  article-title: Cluster randomization trial of sequence mass screening for colorectal cancer
  publication-title: Dis Colon Rectum
  doi: 10.1007/s10350-004-6496-2
– volume: 45
  start-page: 588
  year: 1999
  ident: 10.1016/j.bpg.2010.06.005_bib19
  article-title: The risks of screening: data from the Nottingham randomised controlled trial of faecal occult blood screening for colorectal cancer
  publication-title: Gut
  doi: 10.1136/gut.45.4.588
SSID ssj0001699
Score 2.1770751
SecondaryResourceType review_article
Snippet The incidence of colorectal cancer (CRC) has been increasing during the past decades, and the lifetime risk for CRC in industrialised countries is about 5%....
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 417
SubjectTerms Aged
Clinical Trials as Topic
Colonoscopy
Colorectal cancer
Colorectal cancer screening
Colorectal Neoplasms - diagnosis
Colorectal Neoplasms - epidemiology
Colorectal Neoplasms - mortality
Colorectal Neoplasms - prevention & control
Early Detection of Cancer - statistics & numerical data
Female
Gastroenterology and Hepatology
Humans
Male
Mass Screening - methods
Middle Aged
Occult Blood
Sigmoidoscopy
Title Evidence for colorectal cancer screening
URI https://www.clinicalkey.com/#!/content/1-s2.0-S1521691810000661
https://www.clinicalkey.es/playcontent/1-s2.0-S1521691810000661
https://dx.doi.org/10.1016/j.bpg.2010.06.005
https://www.ncbi.nlm.nih.gov/pubmed/20833346
https://www.proquest.com/docview/1032751209
https://www.proquest.com/docview/754004344
Volume 24
WOSCitedRecordID wos000283392300007&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVESC
  databaseName: Elsevier SD Freedom Collection Journals 2021
  customDbUrl:
  eissn: 1532-1916
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0001699
  issn: 1521-6918
  databaseCode: AIEXJ
  dateStart: 19990401
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Zb9NAEF6FFCFeEDeBUvmBB0Tkyseej6UqAiQqpBYpb6u1ve6hyonspOrPZ8a76wRKyyHxYkW2N2vPfJ7ZOZeQN5WsFFgNZVwZbsFAUTY2VNoYwKGMKY1htOg3mxCHh3I2U19Ho6NQC3N5IZpGXl2pxX9lNZwDZmPp7F-we_hTOAG_gelwBLbD8Y8YH_YJ7RMIsSc1yjTsAoL8bacgJsB0DQorhHMNul36oLlEp7TopgWoi6GGqgeI7wt0ujvdD-WUJ6ZbtnNs69n-4J5_j-m_p2bl8LCZmu8dDBvpbd7rFSpf1mlGvaDM0pgrLzttEJ5ZDPYf35SurkLao4huiErqaja91qWu_PmaQHe-hfPdYnHi8_AweMTW2mvIKTzCR8In6iMWHE3irUwwJcdka-_TwezzoKDhLtW30fWvEILdfdrfTxPdtFy5yRzplyXHD8kDb09Eew4Hj8jINo_JvS8-Y-IJeRvgEAEcojUcIgeHaIDDU_Ltw8Hx_sfY744Rl1SyZZxWosi4oDXPsFt8ysqqNpjUJMCCLGohbEUZSnRJ0zJLLFwyzIJ8hkFJneT5MzJu5o19QaK8krWsGS9YqcBcN6qAdTtnhleMGy7phCSBCLr0reNxB5MLHXIEzzXQTSPddJ8nySbk3TBk4fqm3HZzFiirQ0EwqDANILhtkPjVINv5b7HTqe4ynehrwJgQOoz060y3fvzdhNuB6Xo9R5IDyLAAfUKi4TKIaIy7mcbOV50WDBVlToGOzx1WBpJkYAHlOeUv_-2RXpH76y92m4yX7cq-JnfLy-VZ1-6QO2Imdzz6vwNOKbos
linkProvider Elsevier
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Evidence+for+colorectal+cancer+screening&rft.jtitle=Bailli%C3%A8re%27s+best+practice+%26+research.+Clinical+gastroenterology&rft.au=Bretthauer%2C+Michael&rft.date=2010-08-01&rft.pub=Elsevier+Ltd&rft.issn=1521-6918&rft.eissn=1532-1916&rft.volume=24&rft.issue=4&rft.spage=417&rft.epage=425&rft_id=info:doi/10.1016%2Fj.bpg.2010.06.005&rft.externalDocID=S1521691810000661
thumbnail_m http://cvtisr.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F15216918%2FS1521691810X00051%2Fcov150h.gif